Oxford Biomedica. 2005 to see 'Huge value creation' (Panmure Gordon)

rrr, interesting post. Particularly as OXB state a consortium want to put money in to accelerate Monudin into the clinic. AK is presenting on the 'use of lentivirus' in early December. We could recieve an update on a few of the Neuro products at that stage. We are due an update on Retinostat before year end:


CONFERENCES:
December 02 'use of Lentivirus' by Alan Kingsman